Skip to main content
American Journal of Alzheimer's Disease and Other Dementias logoLink to American Journal of Alzheimer's Disease and Other Dementias
. 2014 Sep 26;30(4):405–411. doi: 10.1177/1533317514552318

Smoking and Cognitive Impairment Among Older Persons in Malaysia

Yadollah Abolfathi Momtaz 1,2, Rahimah Ibrahim 1,3, Tengku Aizan Hamid 1,3,, Sen Tyng Chai 1
PMCID: PMC10852561  PMID: 25260596

Abstract

Introduction:

Previous studies have shown conflicting results on the association between smoking and cognitive function. This study aims to examine the relationship of smoking with cognitive function.

Methodology:

Data for the study, consisting of 2553 older adults aged 60 years and older, were drawn from a nationwide household survey entitled “Determinants of Wellness among Older Malaysians: A Health Promotion Perspective” conducted in 2010.

Results:

Current smokers had lower rates of cognitive impairment compared to never smokers (17.4% vs 25.9%), while cognitive function in former or ex-smokers was almost similar to that of the never smokers. Findings from multiple logistic regression analysis showed that current smokers were 37% less likely to be cognitively impaired, compared to the never smokers (odds ratio [OR] = .63; 95% confidence interval [CI]: .46-.86) while controlling for potential confounders. No difference in cognitive function was observed between former smokers and never smokers (OR = .94; 95% CI: .71-1.25).

Conclusion:

Although the findings indicated a negative association between cigarette smoking and cognitive impairment, we are unable to conclude whether this relationship is causal or affected by other unmeasured confounding factors, especially survival bias.

Keywords: aged, cigarette smoking, cognitive impairment, Malaysia

Introduction

With the rapidly aging global population, cognitive impairment in old age is a growing worldwide concern. 1,2 Since there is no absolute cure for cognitive disorders, 3 a growing body of research has been focusing on identifying modifiable risk factors contributing to the condition. In light of this, one of the risk factors that has been widely studied is cigarette smoking. Although there is evidence to support that cigarette smoking has considerable adverse effects on health and that smoking contributes to many age-related diseases, 4 -6 studies have produced conflicting findings on the association between smoking and dementia. 7 Observational studies suggest that smoking might be protective against Alzheimer’s disease (AD), 8 -10 whereas longitudinal studies have found that smokers have the same 11 -13 or increased risk of dementia and AD. 14 -16 For example, the findings from 2 meta-analyses of longitudinal studies concluded by Anstey et al 16 as well as Peters et al 17 have shown that current smoking is associated with an increased risk of dementia.

Although majority of the previous prospective studies have found that smoking increases the risk of dementia, surprisingly, the findings from a recent longitudinal study conducted by Wang and his colleagues 18 indicated that smokers were less likely to develop cognitive impairment compared to never smokers, after controlling for age, education, hypertension, diabetes, heart disease, and stroke at baseline. The study suggested that smoking might have protective effect for cognitive function.

In sum, a review of research focusing on the association between smoking and cognitive function shows apparently conflicting results, especially between cross-sectional and longitudinal studies. Several studies have found that smoking improves cognitive function; however, some other studies have found that smoking is associated with increased risk of dementia. Therefore, the impact of smoking on cognitive performance needs more clarification. 18 The current cross-sectional study aimed to examine the association between smoking and cognitive function among community-dwelling elderly individuals.

Methodology

Data for this cross-sectional study were drawn from a nationally representative household survey entitled “Determinants of Wellness among Older Malaysians: A Health Promotion Perspective” conducted in 2010. The methodology of the study has been previously published elsewhere. 19 Briefly, the survey used a 2-stage proportional random sampling technique to obtain a sample of 2562 older adults aged 60 years and older, with a response rate of 77%. The primary sampling units were Census enumeration blocks. The secondary sampling units were private households randomly selected from the list of all enumerated households in each block. All selected respondents were interviewed by trained enumerators. The final sample size after data cleaning was 2553 respondents.

Ethics and Approval

The study was approved by the Ministry of Health, Malaysia, and was in compliance with the Declaration of Helsinki and the World Medical Association guidelines. After providing a disclosure statement about the purpose of the survey, oral informed consent was obtained from all respondents before commencing the interview.

Measures

Cognitive Impairment

The main outcome variable was cognitive impairment, measured using with the Mini-Mental State Examination (MMSE). The MMSE assesses 5 areas of cognitive function including orientation, attention, calculation, language, and recall. The cutoff point 18 of 19 was used for detecting cognitive impairment in illiterate respondents and 24 of 25 was used for the educated. 20,21

History of Smoking

Respondents were asked whether they have ever smoked and whether they are still smoking. Based on the responses, respondents were classified into 3 main categories: never smokers, current smokers, and former smokers.

Chronic Medical Conditions

Chronic medical conditions (CMCs) were assessed using a checklist of self-reported chronic health problems including hypertension, heart disease, stroke, diabetes, cancer, visual problems, hearing problems, gastritis, asthma, kidney disease, joint pain (arthritis), and tuberculosis during the previous 12 months. The number of chronic medical conditions was categorized into 3 categories: zero, 1 to 2, and 3 or more.

Sociodemographic Factors

Sociodemographic characteristics, including age, education (in years), gender, and household income, were included in the analysis.

Statistical Analysis

The data were analyzed using SPSS version 21. A 2-step hierarchical logistic regression model was used to determine unique effect of smoking on cognitive impairment after controlling for potential confounders. Hosmer-Lemeshow tests were used to determine goodness of fit for the hierarchical logistic regression models. The P value criterion used for evaluating statistical significance was .05. Smoking status was entered in the first block. Sociodemographic factors and health factors were included in the second model, namely the variables on age, gender, educational attainment, household income, and CMCs.

Results

Table 1 presents the smoking status and demographic characteristics of the study respondents by their cognitive function. As can be seen from Table 1, 55% of the 2553 respondents who participated in the survey were women, and 40% of the respondents had no formal education. Less than one-fifth (15.9%) of the study participants indicated that they were current smokers, 17% were former smokers, and 67.1% reported having never smoked. The prevalence of cognitive impairment among current smokers was 17.4%. The former smokers and never smoked had a similar prevalence of cognitive impairment (24.5% vs 25.9%). A 1-way analysis of variance was used to test for differences in cognitive function among the 3 groups. Since the assumption of homogeneity of variance was violated (Levene Statistic = 14.94, P ≤ .05), the Brown Forsythe F ratio was reported. There was a significant difference in cognitive function among respondents by smoking history, F 2, 1248.13 = 20.84, P < .001. Tukey post hoc comparisons of the 3 groups indicated that the mean cognitive function score of the current smokers (M = 25.86, standard deviation [SD] = 4.68) was significantly higher than the former smokers (M = 24.43, SD = 5.56) and never smokers (M = 23.99, SD = 5.78).

Table 1.

Distribution of Study Variables by Cognitive Impairment.a

Variable Category Total Noncognitively Impaired Cognitively Impaired χ2



n % n % n %
Smoking status Never smokers 1713 67.1 1269 65.7 444 71.5 12.84b
Former smokers 433 17.0 327 16.9 106 17.1
Current smokers 407 15.9 336 17.4 71 11.4
Gender Male 1150 45.0 903 46.7 247 39.8 9.21b
Female 1403 55.0 1029 53.3 374 60.2
Age <68 1219 47.7 1005 52.0 214 34.5 58.07c
>68 1334 52.3 927 48.0 407 65.5
Household income, RM <300 769 30.1 522 27.0 247 39.8 46.83c
300-800 1144 44.8 876 45.3 268 43.2
>800 640 25.1 534 27.6 106 17.1
CMC No CMC 466 18.3 376 19.5 90 14.5 17.10c
1-2 CMC 1320 51.7 1013 52.4 307 49.4
3+ CMCs 767 30.0 543 28.1 224 36.1
Education No Formal 1022 40.0 732 37.9 290 46.7 37.72c
Primary 1155 45.2 871 45.1 284 45.7
Secondary and tertiary 376 14.7 329 17.0 47 7.57

Abbreviations: CMC, chronic medical condition; RM: Ringgit Malaysia.

a P ≤ .05.

b P < .01.

c P < .001.

The results of chi-square analyses presented in Table 1 showed significant association between cognitive impairment with smoking status (χ2 = 12.84, P < .001), gender (χ2 = 9.21, P < .01), age (χ2 = 58.07, P < .001), household income (χ2 = 46.83, P < .001), CMCs (χ2 = 17.10, P < .001), and educational attainment (χ2 = 37.72, P < .001).

A series of chi-square analyses were also performed to examine the relationships between the sociodemographic variables and smoking status (see Table 2). The findings revealed significant associations between smoking status, gender (χ2 = 742.58, P < .001), marital status (χ2 = 97.99, P < .001), household income (χ2 = 24.20, P < .001), CMCs (χ2 = 27.38, P < .001), and educational attainment (χ2 = 36.81, P < .001).

Table 2.

Distribution of Study Variables by Smoking Status.a,b

Smoking status

Never Smokers Past Smoker Current Smokers



Variable Category n % n % n % χ2
Gender Male 450 26.3 353 81.5 347 85.3 742.58c
Female 1263 73.7 80 18.5 60 14.7
Age <68 822 48.0 190 43.9 207 50.9 4.22
>68 891 52.0 243 56.1 200 49.1
Household Income <300 557 32.5 101 23.3 111 27.3 24.20c
300-800 762 44.5 191 44.1 191 46.9
>800 394 23.0 141 32.6 105 25.8
CMC No CMC 301 17.6 62 14.3 103 25.3 27.38c
1-2 CMCs 877 51.2 227 52.4 216 53.1
3+ CMCs 535 31.2 144 33.3 88 21.6
Education No formal 755 44.1 145 33.5 122 30.0 36.81c
Primary 725 42.3 214 49.4 216 53.1
Secondary and Tertiaryt 233 13.6 74 17.1 69 17.0

Abbreviation: CMCs, chronic medical conditions.

a P ≤ .05.

b P < .01.

c P < .001.

Hierarchical Logistic Regression

The first block (smoking history) was significant according to the model chi-square statistics. Current smokers had a lower risk of cognitive impairment than never smokers (odds ratio [OR] = .60; 95% confidence interval [CI], .46-.80). The findings from block 2 also revealed a significant model where smoking status remained a significant factor that contributed toward cognitive impairment at P = .01 while controlling for potential confounders such as age, gender, educational attainment, household income, and chronic medical conditions. Table 3 showed that there are no significant difference between former smokers and never smokers (OR = .94, 95% CI: 0.71-1.25).

Table 3.

Summary of Hierarchical Logistic Regression Model.

Variable Block 1 Block 2


OR 95% CI OR 95% CI


Lower Upper Lower Upper
Smoking status
 Past smoker 0.93 0.73 1.18 0.94 0.71 1.25
 Current smoker 0.60a 0.46 0.8 0.63b 0.46 0.86
Age 1.82a 1.49 2.22
Female 1 0.79 1.26
Education (Ref: no formal)
 Primary 1.14 0.92 1.4
 Secondary and tertiary 0.63c 0.43 0.91
Household Income (Ref: <300)
 300-800 0.7b 0.57 0.87
 >800 0.53a 0.4 0.7
CMCs (Ref: no CMC)
 1-2 CMCs 1.2 0.92 1.57
 3+ CMCs 1.45c 1.09 1.94
Model statistics
χ2 13.61 123.66
df 2 10
Model significance <0.001 <0.001

Abbreviations: CI, confidence interval; CMCs, chronic medical conditions; OR, odds ratio.

a P < .001.

b P < .01.

c P ≤ .05.

Discussion

The prevalence of cigarette smoking among older Malaysians aged 60 years and older in the present study was found to be 15.9% (30.2% among males and 4.3% among females), similar to the national prevalence rate of smoking among older adults. 22 The study provided evidence of a lower rate of current smoker status among cognitively impaired respondents compared to the respondents without cognitive impairment (11.1% vs 17%).

The main purpose of this cross-sectional study was to examine the association between smoking and cognitive function. Consistent with previous studies of similar research design, 18,23 we found an inverse relationship between smoking and cognitive impairment. The findings are inconsistent with a growing body of empirical evidence, particularly from longitudinal studies, which showed smoking increases the odds of cognitive impairment. 16,24 -29

The finding that showed no significant difference in cognitive function between former smokers and never smokers was consistent with several past studies. 28,30 However, there are other studies which linked smoking history to cognitive function and found that former smokers have better cognitive scores than never smokers. 18,31,32 For example, the findings from a prospective study among older Taiwanese respondent indicated that former smokers had a lower risk of cognitive impairment compared to never smokers, after controlling for age, education, diabetes, hypertension, stroke, and heart disease. 18 Conversely, the results of other studies provided evidence to the contrary where former smokers have a higher rate of cognitive decline. 16,29,33

Although the exact mechanisms by which cigarette smoking contributes to dementia have not yet been completely understood, it is believed that smoking damages the cardiovascular system and causes oxidative stress, the conditions that may increase the risk of dementia and AD. Smoking can increase the risk of AD and dementia through the cardiovascular system. 29 There was evidence that smoking is also a risk factor for hypertension. 34,35 It was found that hypertension is associated with an increased risk of Alzheimer’s disease and dementia through cerebrovascular pathology and Alzheimer’s disease pathology. 16,17,36

Oxidative stress is another mechanism that may explain the negative effect of smoking on cognitive function. Oxidative stress caused by cigarette smoking damages cells in the blood vessels and results in narrowing of the arteries and reducing cerebral blood flow. Consequently, reduced cerebral perfusion may account for cognitive impairment. 24,26 Recent studies showed that oxidative stress plays a significant role in the onset and development of Alzheimer’s disease. 37 -39

Another possible mechanism that may account for the contribution of smoking to cognitive function is through lifestyle factors. Studies have shown that cigarette smoking is associated with increased consumption of alcohol, 40,41 unhealthy body mass index, 42,43 and low physical activity, 44,45 conditions that are considered as leading causes of cognitive impairment. 46,47 Nonphysiological mechanism may also explain the association between cigarettes smoking and cognitive impairment. First, population-based studies have found an inverse association between socioeconomic status (SES) and smoking behavior, whereas people with lower SES are more likely to become smokers. 48,49 Second, several studies have shown that socioeconomic factors may have a role in dementia etiology. 50 -52 Therefore, the link between low SES and smoking habits may partly explain why smokers may be at greater risk of cognitive impairment.

In contrast, the potential biological protective effects of smoking on dementia has been attributed to nicotine. 53,54 Nicotine can improve short-term cognitive performance and inhibits amyloid formation. 16 It stimulates receptors in the brain that are important for thinking and memory. 55,56 Another explanation for negative association between cigarette smoking and cognitive impairment could be owing to the fact that cigarette smokers die at younger ages than nonsmokers, thus creating a survivorship bias. Consequently, fewer smokers are alive at the ages when dementia symptoms typically onset. 57 Therefore, lower rates of dementia among smokers may have little or nothing to do with any protective quality of smoking and actually be attributable to smokers dying early from other diseases before the onset of dementia. 58 For example, in their study, Sabia and colleagues examined whether the smoking–cognition association is underestimated owing to premature mortality among smokers and found that current smokers had a higher risk of dying during follow-up compared to never smokers, after controlling for age, socioeconomic status, and marital status among men and women. 57

Although, our study benefits from a large representative sample of Malaysian older adults 60 years and older, its cross-sectional nature limits causal conclusions. Another important limitation that should be highlighted is that smoking assessment was solely based on self-report. Some studies indicate that respondents tend to underreport socially undesirable behaviors, such as tobacco use, which may result in the underestimation of the association between smoking and cognitive function. The last limitation that should be acknowledged is related to the use of MMSE. Although the MMSE is widely used as an effective screening instrument for cognitive impairment, it relies heavily on the verbal response, reading, and writing. Therefore, nonformal educated respondents may perform poorly in spite of being cognitively intact. 59

Conclusion

The findings from the present cross-sectional research are in accordance with some previous studies which showed that cigarette smoking may be associated with a lower risk of cognitive impairment. It should be acknowledged that from the present study, we are unable to conclude whether the negative association between cigarette smoking and cognitive impairment is causal or due to other unmeasured confounding factors that require further study to identify the biopsychosocial mechanisms linking cigarette smoking to cognitive function.

Acknowledgments

The authors are thankful to the participants in the study, editor, and anonymous reviewers.

Footnotes

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Ministry of Science, Technology and Innovation which funded the research project (IRPA 06-02-04-0461PR0031).

References

  • 1. Momtaz YA, Hamid TA, Yusoff S, Ibrahim R. Do depression and educational attainment mediate the association between ethnicity and dementia? Gerontology. 2012;59 (3):206–212. [DOI] [PubMed] [Google Scholar]
  • 2. Formiga F, Ferrer A, Chivite D, et al. Predictors of cognitive decline in 85-year-old patients without cognitive impairment at baseline: 2-year follow-up of the Octabaix Study. Am J Alzheimers Dis Other Dement. 2013 2013;28 (2):147–153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. News Briefs. Analyst insight: Alzheimer’s efforts shift from cure to prevention: Emerging biomarkers, and possible ties to diabetes. Am J Alzheimers Dis Other Dement. 2012;27 (8):640–651. [Google Scholar]
  • 4. Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol. JAMA. 1999;282 (22):2149–2155. [DOI] [PubMed] [Google Scholar]
  • 5. Gorelick PB, Sacco RL, Smith DB, et al. Prevention of a first stroke. JAMA. 1999;281 (12):1112–1120. [DOI] [PubMed] [Google Scholar]
  • 6. Ford AB, Mefrouche Z, Friedland RP, Debanne SM. Smoking and cognitive impairment: A population-based study. J Am Geriatr Soc. 1996;44 (8):905–909. [DOI] [PubMed] [Google Scholar]
  • 7. Almeida OP, Hulse GK, Lawrence D, Flicker L. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction. 2002;97 (1):15–28. [DOI] [PubMed] [Google Scholar]
  • 8. Tyas SL. Are tobacco and alcohol use related to Alzheimer's disease? A critical assessment of the evidence and its implications. Addiction Biol. 1996;1 (3):237–254. [DOI] [PubMed] [Google Scholar]
  • 9. Lee PN. Smoking and Alzheimer's disease: A review of the Epidemiological evidence. Neuroepidemiology. 1994;13 (4):131–144. [DOI] [PubMed] [Google Scholar]
  • 10. Fratiglioni L, Wang HX. Smoking and Parkinson's and Alzheimer's disease: Review of the epidemiological studies. Behavioural Brain Res. 2000;113 (1):117–120. [DOI] [PubMed] [Google Scholar]
  • 11. Brayne C, Gill C, Huppert FA, et al. Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord. 1998;9 (3):175–180. [DOI] [PubMed] [Google Scholar]
  • 12. Broe GA, Creasey H, Jorm AF, et al. Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust N Z J Public Health. 1998;22 (5):621–623. [DOI] [PubMed] [Google Scholar]
  • 13. Doll R, Peto R, Boreham J, Sutherland I. Smoking and dementia in male British doctors: Prospective study. BMJ. 2000;320 (7242):1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Merchant C, Tang MX, Albert S, Manly J, Stern Y, Mayeux R. The influence of smoking on the risk of Alzheimer’s disease. Neurology. 1999;52 (7):1408–1408. [DOI] [PubMed] [Google Scholar]
  • 15. Ott A, Slooter AJC, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: The Rotterdam study. Lancet. 1998;351 (9119):1840–1843. [DOI] [PubMed] [Google Scholar]
  • 16. Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies. Am J Epidemiol. 2007;166 (4):367–378. [DOI] [PubMed] [Google Scholar]
  • 17. Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C. Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 2008;8 (1):36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Wang CC, Lu TH, Liao WC, et al. Cigarette smoking and cognitive impairment: A 10-year cohort study in Taiwan. Arch Gerontol Geriatr. 2010;51 (2):143–148. [DOI] [PubMed] [Google Scholar]
  • 19. Momtaz YA, Hamid TA, Ibrahim R, Akahbar SAN. Racial and socioeconomic disparities in sexual activity among older married Malaysians. Arch Gerontol Geriatr. 2014;58 (1):51–55. [DOI] [PubMed] [Google Scholar]
  • 20. LourencoI RA, Vera RP. Mini-mental state examination: psychometric characteristics in elderly outpatients. Rev Saude Publica. 2006;40 (4):712–719. [DOI] [PubMed] [Google Scholar]
  • 21. Momtaz YA, Hamid TA, Ibrahim R. The impact of mild cognitive impairment on sexual Activity. Am J Alzheimers Dis Other Dement. 2013;28 (8):759–762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Lim HK, Ghazali SM, Kee CC, et al. Epidemiology of smoking among Malaysian adult males: prevalence and associated factors. BMC Public Health. 2013;13 (1):8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Levin ED, McClernon FJ, Rezvani AH. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology. 2006;184 (3-4):523–539. [DOI] [PubMed] [Google Scholar]
  • 24. Rusanen M, Kivipelto M, Quesenberry CP, Jr, Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med. 2011;171 (4):333–339. [DOI] [PubMed] [Google Scholar]
  • 25. Gons RAR, van Norden AGW, de Laat KF, et al. Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter. Brain. 2011;134 (7):2116–2124. [DOI] [PubMed] [Google Scholar]
  • 26. Collins N, Sachs-Ericsson N, Preacher KJ, Sheffield KM, Markides K. Smoking increases risk for cognitive decline among community-dwelling older Mexican Americans. Am J Geriatr Psychiatry. 2009;17 (11):934–942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17 (3):259–273. [DOI] [PubMed] [Google Scholar]
  • 28. Nooyens ACJ, van Gelder BM, Verschuren WMM. Smoking and cognitive decline among middle-aged men and women: The Doetinchem Cohort Study. Am J Public Health. 2008;98 (12):2244–2250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Mons U, Schottker B, Muller H, Kliegel M, Brenner H. History of lifetime smoking, smoking cessation and cognitive function in the elderly population. Eur J Epidemiol. 2013;28 (10):823–831. [DOI] [PubMed] [Google Scholar]
  • 30. Galanis DJ, Petrovitch H, Launer LJ, Harris TB, Foley DJ, White LR. Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men: the Honolulu-Asia Aging Study. Am J Epidemiol. 1997;145 (6):507–515. [DOI] [PubMed] [Google Scholar]
  • 31. Sabia S, Elbaz A, Dugravot A, et al. Impact of smoking on cognitive decline in early old age: The Whitehall II cohort study. Arch Gen Psychiatry. 2012;69 (6):627–635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Richards M, Jarvis MJ, Thompson N, Wadsworth MEJ. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health. 2003;93 (6):994–998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Ott A, Andersen K, Dewey ME, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology. 2004;62 (6):920–924. [DOI] [PubMed] [Google Scholar]
  • 34. Halperin RO, Gaziano JM, Sesso HD. Smoking and the risk of incident hypertension in middle-aged and older men. Am J Hypertens. 2008;21 (2):148–152. [DOI] [PubMed] [Google Scholar]
  • 35. Bonita R. Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: A population-based case-control study. Stroke. 1986;17 (5):831–835. [DOI] [PubMed] [Google Scholar]
  • 36. Knopman DS. Hypertension and late-life dementia: a real link? Neurology. 2009;72 (20):1716–1717. [DOI] [PubMed] [Google Scholar]
  • 37. Chong ZZ, Li F, Maiese K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Rev. 2005;49 (1):1–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Khanna A, Guo M, Mehra M, Royal W, III. Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains. J Neuroimmunol. 2013;254 (1):69–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Ho YS, Yang X, Yeung SC, et al. Cigarette smoking accelerated brain aging and induced pre-Alzheimer-like neuropathology in rats. PloS One. 2012;7 (5):e36752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Burns BE, Proctor WR. Cigarette smoke exposure greatly increases alcohol consumption in adolescent C57BL/6 mice. Alcohol Clin Exp Res. 2013;37 (s1):E364–E372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Watten RG. Smokers and non-smokers: differences in alcohol consumption and intake of other health-related substances in Norway: a general population study. Eur J Public Health. 1999;9 (4):306–308. [Google Scholar]
  • 42. Sneve M, Jorde R. Cross-sectional study on the relationship between body mass index and smoking, and longitudinal changes in body mass index in relation to change in smoking status: the Tromso Study. Scand J Public Health. 2008;36 (4):397–407. [DOI] [PubMed] [Google Scholar]
  • 43. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87 (4):801–809. [DOI] [PubMed] [Google Scholar]
  • 44. Furlanetto KC, Mantoani LC, Bisca G, et al. Reduction of physical activity in daily life and its determinants in smokers without airflow obstruction. Respirology. 2014;19 (3):369–375. [DOI] [PubMed] [Google Scholar]
  • 45. Campbell Jenkins B, Sarpong D, Addison C, et al. Joint effects of smoking and sedentary lifestyle on lung function in African Americans: The Jackson Heart Study Cohort. Int J Environ Res Public Health. 2014;11 (2):1500–1519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Sofi F, Valecchi D, Bacci D, et al. Physical activity and risk of cognitive decline: A meta-analysis of prospective studies. J Intern Med. 2011;269 (1):107–117. [DOI] [PubMed] [Google Scholar]
  • 47. de Bruijn RFAG, Schrijvers EMC, de Groot KA, et al. The association between physical activity and dementia in an elderly population: The Rotterdam Study. Eur J Epidemiol. 2013;28 (3):277–283. [DOI] [PubMed] [Google Scholar]
  • 48. Hiscock R, Bauld L, Amos A, Fidler JA, Munafo M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci. 2012;1248 (1):107–123. [DOI] [PubMed] [Google Scholar]
  • 49. Parrish A, Mason C. Low Socioeconomic Status and Cancer Prevention in the American Cancer Society Great West Division. Washington, DC: Health Promotion Research Center; 2013. [Google Scholar]
  • 50. Russ TC, Stamatakis E, Hamer M, Starr JM, Kivimäki M, Batty GD. Socioeconomic status as a risk factor for dementia death: individual participant meta-analysis of 86 508 men and women from the UK. Br J Psychiatry. 2013;203 (1):10–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Yaffe K, Falvey C, Harris TB, et al. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: Prospective study. BMJ. 2013;347:f7051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Hamid TA, Krishnaswamy S, Abdullah SS, Momtaz YA. Sociodemographic risk factors and correlates of dementia in older Malaysians. Dement Geriatr Cogn Disord. 2011;30 (6):533–539. [DOI] [PubMed] [Google Scholar]
  • 53. White HK, Levin ED. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease. Psychopharmacology. 1999;143 (2):158–165. [DOI] [PubMed] [Google Scholar]
  • 54. Levin ED. Nicotinic systems and cognitive function. Psychopharmacology. 1992;108 (4):417–431. [DOI] [PubMed] [Google Scholar]
  • 55. Newhouse PA, Potter A, Singh A. Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol. 2004;4 (1):36–46. [DOI] [PubMed] [Google Scholar]
  • 56. Rezvani AH, Levin ED. Cognitive effects of nicotine. Biol Psychiatry. 2001;49 (3):258–267. [DOI] [PubMed] [Google Scholar]
  • 57. Sabia S, Marmot M, Dufouil C, Singh-Manoux A. Smoking history and cognitive function in middle age from the whitehall ii study. Arch Intern Med. 2008;168 (11):1165–1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Debanne SM, Rowland DY, Riedel TM, Cleves MA. Association of Alzheimer's disease and smoking: The case for sibling controls. J Am Geriatr Soc. 2000;48 (7):800–806. [DOI] [PubMed] [Google Scholar]
  • 59. Kurlowicz L, Wallace M. The mini mental state examination (MMSE). J Gerontol Nurs. 1999;25 (5):8–9. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Alzheimer's Disease and Other Dementias are provided here courtesy of SAGE Publications

RESOURCES